EventsThe 1st International Online Conference on Veterinary Sciences
Published
This submission belongs to the session D. Antiviral Therapy of the event The 1st International Online Conference on Veterinary Sciences
Published date
28 Nov, 2025
Academic Editor
author-avatarYongtao Li
Citation
Ai Liu, Yifei Lang, Molecular mechanism of BST2 suppresses SADS-CoV replication by degrading N protein, in Proceedings of The 1st International Online Conference on Veterinary Sciences, 3 December–5 December 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Molecular mechanism of BST2 suppresses SADS-CoV replication by degrading N protein

1. College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China, 611130, China
Abstract

Swine acute diarrhea syndrome coronavirus (SADS-CoV), an emerging alphacoronavirus, leads to fatal diarrhea in piglets and exhibits broad cross-species transmission potential. Bone marrow stromal cell antigen 2 (BST2) is an IFN-induced host protein known to restrict a wide range of enveloped viruses. Previous studies have shown that BST2 inhibits Porcine epidemic diarrhea virus (PEDV) replication through the selective autophagy pathway, suggesting a novel mechanism for its antiviral activity. Given that SADS-CoV and PEDV are phylogenetically related alphacoronaviruses, we hypothesized that BST2 may employ a similar mechanism to antagonize SADS-CoV infection.

To test this hypothesis, we employed TurboID-based proximity labeling combined with co-immunoprecipitation and Western blot analysis. Our results demonstrated that BST2 binds to the SADS-CoV nucleocapsid (N) protein and promotes its degradation, resulting in a significant reduction in viral replication. Further virological assays showed that overexpression of BST2 significantly reduced viral titers, whereas BST2 knockout enhanced viral replication.

These findings establish BST2 as a key host restriction factor against SADS-CoV and reveal a novel antiviral mechanism targeting the viral nucleocapsid. This work advances our understanding of innate immune defenses against coronaviruses and highlights BST2’s potential as a target for developing interventions aimed at enhancing antiviral responses in swine and mitigating zoonotic risks.

Keywords
SADS-CoV
BST2
nucleocapsid protein
antiviral
Antiviral Strategies Against Newcastle Disease: Current Insights and Future Directions
Scorpion-derived peptides as antiviral agents in veterinary medicine